Fennec Pharmaceuticals
FENC
55 hedge funds and large institutions have $83.8M invested in Fennec Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 19 reducing their positions, and 11 closing their positions.
214% more call options, than puts
Call options by funds: $204K | Put options by funds: $65K
0% more funds holding
Funds holding: 55 → 55 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 11
0.16% less ownership
Funds ownership: 54.7% → 54.54% (-0.16%)
26% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 19
28% less capital invested
Capital invested by funds: $116M → $83.8M (-$32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
+$1.54M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$1.31M |
| 3 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$357K |
| 4 |
State Street
Boston,
Massachusetts
|
+$327K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$269K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.43M |
| 2 |
SCM
Solas Capital Management
Darien,
Connecticut
|
-$1.13M |
| 3 |
Renaissance Technologies
New York
|
-$1.12M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$889K |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$832K |
FENC Hedge Fund Activity: Q3 2020 in Review
55 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Fennec Pharmaceuticals (FENC) for Q3 2020, worth a combined $83.8M — down 28% from $116M a quarter earlier.
Fund positioning in FENC was balanced in Q3 2020: 11 funds opened new positions, 11 closed out, 14 added to existing stakes and 19 trimmed.
The largest buyer was Russell Investments Group, opening a new position worth an estimated $1.54M. The largest seller was Opaleye Management, exiting entirely with an estimated $1.43M sold.
- 55 institutional investors held Fennec Pharmaceuticals (FENC) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $83.8M of Fennec Pharmaceuticals stock for Q3 2020, down 28% quarter-over-quarter.
- 11 funds opened new Fennec Pharmaceuticals positions in Q3 2020 and 11 closed out, a net change of 0 holders.
- The largest Fennec Pharmaceuticals buyer in Q3 2020 was Russell Investments Group, an estimated $1.54M added.
- The largest Fennec Pharmaceuticals seller in Q3 2020 was Opaleye Management, an estimated $1.43M sold.
Based on aggregated 13F filings for Q3 2020.